ripekg:author/RIPEAU3ECF3C5CDED0CC5BYunfei Chen |
rdf:type |
node1 |
ripekg:author/RIPEAU3ECF3C5CDED0CC5BYunfei Chen |
rdf:type |
rdfs:Resource |
ripekg:author/RIPEAU3ECF3C5CDED0CC5BYunfei Chen |
rdf:type |
owl:Thing |
ripekg:author/RIPEAU3ECF3C5CDED0CC5BYunfei Chen |
rdf:type |
prov:Person |
ripekg:author/RIPEAU3ECF3C5CDED0CC5BYunfei Chen |
rdf:type |
foaf:Person |
ripekg:author/RIPEAU3ECF3C5CDED0CC5BYunfei Chen |
rdf:type |
ripe:AuthorAuthor |
ripekg:author/RIPEAU3ECF3C5CDED0CC5BYunfei Chen |
owl:sameAs |
https://semopenalex.org/author/A5101739518 |
ripekg:author/RIPEAU3ECF3C5CDED0CC5BYunfei Chen |
foaf:familyName |
Chen |
ripekg:author/RIPEAU3ECF3C5CDED0CC5BYunfei Chen |
foaf:givenName |
Yunfei |
ripekg:author/RIPEAU3ECF3C5CDED0CC5BYunfei Chen |
foaf:name |
Yunfei Chen |
ripekg:retraction-notice/58899Research on Spectrum Feature Identification of Indoor Multimodal Communication Signal |
ripe:concerns |
ripekg:author/RIPEAU3ECF3C5CDED0CC5BYunfei Chen |
ripekg:work/10.1136%2Fbmj-2025-084314Anti-CD38 monoclonal antibody CM313 for primary immune thrombocytopenia: multicentre, randomised, placebo controlled, phase 2 trial |
dcterms:creator |
ripekg:author/RIPEAU3ECF3C5CDED0CC5BYunfei Chen |